• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Validity of the test for attentional performance in neurological post-COVID condition

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Jul 7;15(1):24208.
doi: 10.1038/s41598-025-09128-2. Validity of the test for attentional performance in neurological post-COVID condition

Susan Seibert[SUP] 1 2 [/SUP], Irina Eckert[SUP] 3 [/SUP], Catherine N Widmann[SUP] 4 5 [/SUP], Taraneh Ebrahimi[SUP] 4 5 [/SUP], Fabian Bösl[SUP] 5 3 [/SUP], Christiana Franke[SUP] 3 [/SUP], Harald Prüss[SUP] 3 6 [/SUP], Joachim L Schultze[SUP] 5 7 [/SUP], Gabor C Petzold[SUP] 4 5 [/SUP], Omid Shirvani[SUP] 4 5 [/SUP]



Affiliations
Abstract

Neurological post-COVID condition (PCC) often involves attentional deficits that impact daily functioning. Traditional paper-based tests, like the Trail-Making Test (TMT), may inadequately capture these impairments due to their short duration and dependence on numerical and alphabetic sequencing. This study evaluates the validity of three subtests of the computerized Test for Attentional Performance (TAP) as alternatives for detecting attentional impairments in PCC. In the ongoing NEURO LC-19 DE study, 108 subjects aged 18 to 79 years, with PCC-related cognitive complaints (n = 67, 73% f) and healthy controls (n = 41, 56% f) underwent neuropsychological testing. The prevalence of impairment and classification ability of the TAP subtests were evaluated alongside standard paper-based tests, including the TMT and Montreal Cognitive Assessment, using receiver operating characteristic (ROC) analysis and regression. The TAP subtests identified significant impairments in sustained attention and processing speed in one-third of PCC patients, surpassing traditional tests in sensitivity, and classifying PCC with an AUC of 78%. Omissions in sustained attention significantly differentiated groups (OR = 1.14, p = 0.016, 95% CI [1.02-1.26]). Fatigue correlated with poorer performance on speed and accuracy (r > 0.30, p < 0.05). Cognitive slowing is prevalent in neurological PCC but is scarcely captured by conventional assessments. The TAP's computerized format with automated norming and independence from alphanumeric stimuli shows promise in improving the discriminatory ability for identifying attentional deficits in PCC patients.

Keywords: COVID-19; Cognitive impairment; Complex attention; Neuropsychological assessment; Post-/Long-COVID; Test battery.

 
Back
Top Bottom